CDKN2 mutations in melanoma

Cancer Surv. 1996:26:115-32.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Carrier Proteins / genetics*
  • Cyclin-Dependent Kinase Inhibitor p16
  • Disease Progression
  • Genes, Tumor Suppressor*
  • Genetic Heterogeneity
  • Heterozygote
  • Humans
  • Melanoma / diagnosis
  • Melanoma / genetics*
  • Melanoma / therapy
  • Mutation
  • Periodicity
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / therapy

Substances

  • Carrier Proteins
  • Cyclin-Dependent Kinase Inhibitor p16